Incannex Healthcare Inc.
Incannex Healthcare Inc. (IXHL): 4 pipeline candidates · 1 upcoming catalyst · ~93 mo cash runway · 3 clinical trials. Updated within the last hour.
BioSniper Score
5-factor signal · derived from public data
93.0 months
D/E 0.07 · 0% dilution
Lead: Phase 2/Phase 3
4 candidates
1 upcoming, next in ~166d
N/A
A transparent, data-derived signal for Incannex Healthcare Inc.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$43.9M
Cash
$74.5M
Quarterly Burn
$2.5M
Runway
93.0 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (4 candidates)
| Drug | Phase |
|---|---|
| hydroxychloroquine | Phase 2 |
| ihl-42x | Phase 2/Phase 3 |
| ihl-675a | Phase 2 |
| psx-001 | Phase 2 |
Upcoming Catalysts (1)
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
14
Total value held
$1.1M
| Holder | Shares | Value |
|---|---|---|
| ghisallo capital management llc | 162,855 | $489K |
| mirae asset global etfs holdings ltd. | 149,857 | $450K |
| advisorshares investments llc | 24,503 | $74K |
| commonwealth equity services, llc | 12,112 | $36K |
| osaic holdings, inc. | 6,376 | $19K |
| morgan stanley | 2,065 | $6K |
| quent capital, llc | 1,928 | $6K |
| jpmorgan chase & co | 825 | $3K |
| barclays plc | 750 | $2K |
| larson financial group llc | 59 | $177 |
Showing top 10 of 14 institutional holders of Incannex Healthcare Inc.. Sign up for the full 13F holder list and quarter-by-quarter ownership history.
Frequently asked questions
How many drug candidates are in Incannex Healthcare Inc.'s pipeline?
Incannex Healthcare Inc. (IXHL) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Incannex Healthcare Inc.'s lead drug candidate?
Incannex Healthcare Inc.'s most advanced tracked candidate is hydroxychloroquine (Phase 2) for Rheumatoid Arthritis.
What is Incannex Healthcare Inc.'s next catalyst?
Incannex Healthcare Inc.'s next tracked catalyst is a Phase3_Topline event — "Phase 3 Topline: A Phase II/III, Randomised, Double-Blind Clinical Trial to Determine the Safety and Efficacy of IHL-" — expected December 1, 2026.
What is Incannex Healthcare Inc.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, Incannex Healthcare Inc. has approximately 93.0 months of cash runway.
What is Incannex Healthcare Inc.'s market capitalization?
Incannex Healthcare Inc.'s market capitalization is approximately $43.9M.
Get the full picture on Incannex Healthcare Inc.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.